Clinical Trial Update: Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on temozolomide for patients with recurrent or progressive malignant glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Malignant Glioma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Herbert Irving Comprehensive Cancer Center | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: UNKNOWN